Selected research
Industry Research
Pharmaceutical Validation Services Industry Research Report 2026
Market perspective
The global Pharmaceutical Validation Services market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Pharmaceutical Validation Services market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Pharmaceutical Validation Services market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Pharmaceutical Validation Services market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Pharmaceutical Validation Services include Arbor Group, ATS Global, Catalent, CRS Pharma Solutions, Eurofins Scientific, Körber Pharma, Merck Millipore, MTS (Meissner Technical Services) and Navitas pharma READY, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Pharmaceutical Validation Services market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Pharmaceutical Validation Services.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Pharmaceutical Validation Services Market by Company
Arbor Group
ATS Global
Catalent
CRS Pharma Solutions
Eurofins Scientific
Körber Pharma
Merck Millipore
MTS (Meissner Technical Services)
Navitas pharma READY
PharmOut
SGS
Sigma-Aldrich
SL Controls
Transcat
Pharmaceutical Validation Services Segment by Type
Pharmaceutical Cleaning Validation Services
Pharmaceutical Equipment Validation Services
Others
Pharmaceutical Validation Services Segment by Application
Pharmaceutical Companies
Biotechnological Companies
Academic and Research Institutes
Pharmaceutical Validation Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Validation Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Validation Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Validation Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Pharmaceutical Validation Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Pharmaceutical Cleaning Validation Services
- Pharmaceutical Equipment Validation Services
- Others
Applications
- Pharmaceutical Companies
- Biotechnological Companies
- Academic and Research Institutes
Companies covered
- Arbor Group
- ATS Global
- Catalent
- CRS Pharma Solutions
- Eurofins Scientific
- Körber Pharma
- Merck Millipore
- MTS (Meissner Technical Services)
- Navitas pharma READY
- PharmOut
- SGS
- Sigma-Aldrich
- SL Controls
- Transcat
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Pharmaceutical Validation Services by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Pharmaceutical Cleaning Validation Services
- 2.2.3 Pharmaceutical Equipment Validation Services
- 2.2.4 Others
- 2.3 Pharmaceutical Validation Services by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Pharmaceutical Companies
- 2.3.3 Biotechnological Companies
- 2.3.4 Academic and Research Institutes
- 2.4 Assumptions and Limitations
3 Pharmaceutical Validation Services Breakdown Data by Type
- 3.1 Global Pharmaceutical Validation Services Historic Market Size by Type (2021-2026)
- 3.2 Global Pharmaceutical Validation Services Forecasted Market Size by Type (2027-2032)
4 Pharmaceutical Validation Services Breakdown Data by Application
- 4.1 Global Pharmaceutical Validation Services Historic Market Size by Application (2021-2026)
- 4.2 Global Pharmaceutical Validation Services Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Pharmaceutical Validation Services Market Perspective (2021-2032)
- 5.2 Global Pharmaceutical Validation Services Growth Trends by Region
- 5.2.1 Global Pharmaceutical Validation Services Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Pharmaceutical Validation Services Historic Market Size by Region (2021-2026)
- 5.2.3 Pharmaceutical Validation Services Forecasted Market Size by Region (2027-2032)
- 5.3 Pharmaceutical Validation Services Market Dynamics
- 5.3.1 Pharmaceutical Validation Services Industry Trends
- 5.3.2 Pharmaceutical Validation Services Market Drivers
- 5.3.3 Pharmaceutical Validation Services Market Challenges
- 5.3.4 Pharmaceutical Validation Services Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Pharmaceutical Validation Services Players by Revenue
- 6.1.1 Global Top Pharmaceutical Validation Services Players by Revenue (2021-2026)
- 6.1.2 Global Pharmaceutical Validation Services Revenue Market Share by Players (2021-2026)
- 6.2 Global Pharmaceutical Validation Services Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Pharmaceutical Validation Services Head Office and Area Served
- 6.4 Global Pharmaceutical Validation Services Players, Product Type & Application
- 6.5 Global Pharmaceutical Validation Services Manufacturers Established Date
- 6.6 Global Pharmaceutical Validation Services Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Pharmaceutical Validation Services Market Size (2021-2032)
- 7.2 North America Pharmaceutical Validation Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Pharmaceutical Validation Services Market Size by Country (2021-2026)
- 7.4 North America Pharmaceutical Validation Services Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Pharmaceutical Validation Services Market Size (2021-2032)
- 8.2 Europe Pharmaceutical Validation Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Pharmaceutical Validation Services Market Size by Country (2021-2026)
- 8.4 Europe Pharmaceutical Validation Services Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Pharmaceutical Validation Services Market Size (2021-2032)
- 9.2 Asia-Pacific Pharmaceutical Validation Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Pharmaceutical Validation Services Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Pharmaceutical Validation Services Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Pharmaceutical Validation Services Market Size (2021-2032)
- 10.2 South America Pharmaceutical Validation Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Pharmaceutical Validation Services Market Size by Country (2021-2026)
- 10.4 South America Pharmaceutical Validation Services Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Pharmaceutical Validation Services Market Size (2021-2032)
- 11.2 Middle East & Africa Pharmaceutical Validation Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Pharmaceutical Validation Services Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Pharmaceutical Validation Services Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Arbor Group
- 12.1.1 Arbor Group Company Information
- 12.1.2 Arbor Group Business Overview
- 12.1.3 Arbor Group Revenue in Pharmaceutical Validation Services Business (2021-2026)
- 12.1.4 Arbor Group Pharmaceutical Validation Services Product Portfolio
- 12.1.5 Arbor Group Recent Developments
- 12.2 ATS Global
- 12.2.1 ATS Global Company Information
- 12.2.2 ATS Global Business Overview
- 12.2.3 ATS Global Revenue in Pharmaceutical Validation Services Business (2021-2026)
- 12.2.4 ATS Global Pharmaceutical Validation Services Product Portfolio
- 12.2.5 ATS Global Recent Developments
- 12.3 Catalent
- 12.3.1 Catalent Company Information
- 12.3.2 Catalent Business Overview
- 12.3.3 Catalent Revenue in Pharmaceutical Validation Services Business (2021-2026)
- 12.3.4 Catalent Pharmaceutical Validation Services Product Portfolio
- 12.3.5 Catalent Recent Developments
- 12.4 CRS Pharma Solutions
- 12.4.1 CRS Pharma Solutions Company Information
- 12.4.2 CRS Pharma Solutions Business Overview
- 12.4.3 CRS Pharma Solutions Revenue in Pharmaceutical Validation Services Business (2021-2026)
- 12.4.4 CRS Pharma Solutions Pharmaceutical Validation Services Product Portfolio
- 12.4.5 CRS Pharma Solutions Recent Developments
- 12.5 Eurofins Scientific
- 12.5.1 Eurofins Scientific Company Information
- 12.5.2 Eurofins Scientific Business Overview
- 12.5.3 Eurofins Scientific Revenue in Pharmaceutical Validation Services Business (2021-2026)
- 12.5.4 Eurofins Scientific Pharmaceutical Validation Services Product Portfolio
- 12.5.5 Eurofins Scientific Recent Developments
- 12.6 Körber Pharma
- 12.6.1 Körber Pharma Company Information
- 12.6.2 Körber Pharma Business Overview
- 12.6.3 Körber Pharma Revenue in Pharmaceutical Validation Services Business (2021-2026)
- 12.6.4 Körber Pharma Pharmaceutical Validation Services Product Portfolio
- 12.6.5 Körber Pharma Recent Developments
- 12.7 Merck Millipore
- 12.7.1 Merck Millipore Company Information
- 12.7.2 Merck Millipore Business Overview
- 12.7.3 Merck Millipore Revenue in Pharmaceutical Validation Services Business (2021-2026)
- 12.7.4 Merck Millipore Pharmaceutical Validation Services Product Portfolio
- 12.7.5 Merck Millipore Recent Developments
- 12.8 MTS (Meissner Technical Services)
- 12.8.1 MTS (Meissner Technical Services) Company Information
- 12.8.2 MTS (Meissner Technical Services) Business Overview
- 12.8.3 MTS (Meissner Technical Services) Revenue in Pharmaceutical Validation Services Business (2021-2026)
- 12.8.4 MTS (Meissner Technical Services) Pharmaceutical Validation Services Product Portfolio
- 12.8.5 MTS (Meissner Technical Services) Recent Developments
- 12.9 Navitas pharma READY
- 12.9.1 Navitas pharma READY Company Information
- 12.9.2 Navitas pharma READY Business Overview
- 12.9.3 Navitas pharma READY Revenue in Pharmaceutical Validation Services Business (2021-2026)
- 12.9.4 Navitas pharma READY Pharmaceutical Validation Services Product Portfolio
- 12.9.5 Navitas pharma READY Recent Developments
- 12.10 PharmOut
- 12.10.1 PharmOut Company Information
- 12.10.2 PharmOut Business Overview
- 12.10.3 PharmOut Revenue in Pharmaceutical Validation Services Business (2021-2026)
- 12.10.4 PharmOut Pharmaceutical Validation Services Product Portfolio
- 12.10.5 PharmOut Recent Developments
- 12.11 SGS
- 12.11.1 SGS Company Information
- 12.11.2 SGS Business Overview
- 12.11.3 SGS Revenue in Pharmaceutical Validation Services Business (2021-2026)
- 12.11.4 SGS Pharmaceutical Validation Services Product Portfolio
- 12.11.5 SGS Recent Developments
- 12.12 Sigma-Aldrich
- 12.12.1 Sigma-Aldrich Company Information
- 12.12.2 Sigma-Aldrich Business Overview
- 12.12.3 Sigma-Aldrich Revenue in Pharmaceutical Validation Services Business (2021-2026)
- 12.12.4 Sigma-Aldrich Pharmaceutical Validation Services Product Portfolio
- 12.12.5 Sigma-Aldrich Recent Developments
- 12.13 SL Controls
- 12.13.1 SL Controls Company Information
- 12.13.2 SL Controls Business Overview
- 12.13.3 SL Controls Revenue in Pharmaceutical Validation Services Business (2021-2026)
- 12.13.4 SL Controls Pharmaceutical Validation Services Product Portfolio
- 12.13.5 SL Controls Recent Developments
- 12.14 Transcat
- 12.14.1 Transcat Company Information
- 12.14.2 Transcat Business Overview
- 12.14.3 Transcat Revenue in Pharmaceutical Validation Services Business (2021-2026)
- 12.14.4 Transcat Pharmaceutical Validation Services Product Portfolio
- 12.14.5 Transcat Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst